The high expression levels of DCAF15 in neuroblastoma may explain, in combination with the aforementioned dependence on RBM39, why neuroblastoma is exceptionally sensitive to indisulam treatment in comparison with other cancer lineages. This evidence concerns the gene DCAF15 and neuroblastoma.